- Home
- BBIO vs UBSI Comparison
BBIO vs UBSI Comparison
Compare BBIO & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- UBSI
- Stock Information
- Founded
- BBIO 2015
- UBSI 1982
- Country
- BBIO United States
- UBSI United States
- Employees
- BBIO N/A
- UBSI N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- UBSI Major Banks
- Sector
- BBIO Health Care
- UBSI Finance
- Exchange
- BBIO Nasdaq
- UBSI Nasdaq
- Market Cap
- BBIO 5.1B
- UBSI 5.1B
- IPO Year
- BBIO 2019
- UBSI N/A
- Fundamental
- Price
- BBIO $26.49
- UBSI $38.00
- Analyst Decision
- BBIO Strong Buy
- UBSI Hold
- Analyst Count
- BBIO 13
- UBSI 4
- Target Price
- BBIO $47.92
- UBSI $40.25
- AVG Volume (30 Days)
- BBIO 2.7M
- UBSI 575.4K
- Earning Date
- BBIO 11-12-2024
- UBSI 01-23-2025
- Dividend Yield
- BBIO N/A
- UBSI 3.90%
- EPS Growth
- BBIO N/A
- UBSI N/A
- EPS
- BBIO N/A
- UBSI 2.65
- Revenue
- BBIO $217,765,000.00
- UBSI $1,010,865,000.00
- Revenue This Year
- BBIO $2,648.47
- UBSI N/A
- Revenue Next Year
- BBIO N/A
- UBSI $11.91
- P/E Ratio
- BBIO N/A
- UBSI $14.34
- Revenue Growth
- BBIO 2209.77
- UBSI N/A
- 52 Week Low
- BBIO $21.62
- UBSI $30.68
- 52 Week High
- BBIO $44.32
- UBSI $44.43
- Technical
- Relative Strength Index (RSI)
- BBIO 49.05
- UBSI 33.31
- Support Level
- BBIO $25.34
- UBSI $40.21
- Resistance Level
- BBIO $28.15
- UBSI $41.99
- Average True Range (ATR)
- BBIO 1.33
- UBSI 1.03
- MACD
- BBIO -0.24
- UBSI -0.58
- Stochastic Oscillator
- BBIO 24.73
- UBSI 16.19
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in two segments: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services; and Mortgage banking, which offers and acquires home mortgages through an indirectly owned subsidiary. Nearly all revenue comes from the community banking segment.